414 related articles for article (PubMed ID: 34536819)
21. Phosphorylated protein kinases associated with neuronal and glial tau deposits in argyrophilic grain disease.
Ferrer I; Barrachina M; Tolnay M; Rey MJ; Vidal N; Carmona M; Blanco R; Puig B
Brain Pathol; 2003 Jan; 13(1):62-78. PubMed ID: 12580546
[TBL] [Abstract][Full Text] [Related]
22. Secernin-1 is a novel phosphorylated tau binding protein that accumulates in Alzheimer's disease and not in other tauopathies.
Pires G; McElligott S; Drusinsky S; Halliday G; Potier MC; Wisniewski T; Drummond E
Acta Neuropathol Commun; 2019 Dec; 7(1):195. PubMed ID: 31796108
[TBL] [Abstract][Full Text] [Related]
23. Motor neuron TDP-43 proteinopathy in progressive supranuclear palsy and corticobasal degeneration.
Riku Y; Iwasaki Y; Ishigaki S; Akagi A; Hasegawa M; Nishioka K; Li Y; Riku M; Ikeuchi T; Fujioka Y; Miyahara H; Sone J; Hattori N; Yoshida M; Katsuno M; Sobue G
Brain; 2022 Aug; 145(8):2769-2784. PubMed ID: 35274674
[TBL] [Abstract][Full Text] [Related]
24. Detection of Alzheimer's disease (AD) specific tau pathology with conformation-selective anti-tau monoclonal antibody in co-morbid frontotemporal lobar degeneration-tau (FTLD-tau).
Gibbons GS; Kim SJ; Robinson JL; Changolkar L; Irwin DJ; Shaw LM; Lee VM; Trojanowski JQ
Acta Neuropathol Commun; 2019 Mar; 7(1):34. PubMed ID: 30832741
[TBL] [Abstract][Full Text] [Related]
25. Tau Interacting Proteins: Gaining Insight into the Roles of Tau in Health and Disease.
Stancu IC; Ferraiolo M; Terwel D; Dewachter I
Adv Exp Med Biol; 2019; 1184():145-166. PubMed ID: 32096036
[TBL] [Abstract][Full Text] [Related]
26. Ultrasensitive and selective detection of 3-repeat tau seeding activity in Pick disease brain and cerebrospinal fluid.
Saijo E; Ghetti B; Zanusso G; Oblak A; Furman JL; Diamond MI; Kraus A; Caughey B
Acta Neuropathol; 2017 May; 133(5):751-765. PubMed ID: 28293793
[TBL] [Abstract][Full Text] [Related]
27. Argyrophilic grain disease is a sporadic 4-repeat tauopathy.
Togo T; Sahara N; Yen SH; Cookson N; Ishizawa T; Hutton M; de Silva R; Lees A; Dickson DW
J Neuropathol Exp Neurol; 2002 Jun; 61(6):547-56. PubMed ID: 12071638
[TBL] [Abstract][Full Text] [Related]
28. The Abundance of Nonphosphorylated Tau in Mouse and Human Tauopathy Brains Revealed by the Use of Phos-Tag Method.
Kimura T; Hatsuta H; Masuda-Suzukake M; Hosokawa M; Ishiguro K; Akiyama H; Murayama S; Hasegawa M; Hisanaga S
Am J Pathol; 2016 Feb; 186(2):398-409. PubMed ID: 26687814
[TBL] [Abstract][Full Text] [Related]
29. Structure of NFT: Biochemical Approach.
Hasegawa M
Adv Exp Med Biol; 2019; 1184():23-34. PubMed ID: 32096025
[TBL] [Abstract][Full Text] [Related]
30. Differential vulnerability of the dentate gyrus to tauopathies in dementias.
Kawles A; Minogue G; Zouridakis A; Keszycki R; Gill N; Nassif C; Coventry C; Zhang H; Rogalski E; Flanagan ME; Castellani R; Bigio EH; Mesulam MM; Geula C; Gefen T
Acta Neuropathol Commun; 2023 Jan; 11(1):1. PubMed ID: 36597124
[TBL] [Abstract][Full Text] [Related]
31. Phosphorylated c-MYC expression in Alzheimer disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
Ferrer I; Blanco R; Carmona M; Puig B
Neuropathol Appl Neurobiol; 2001 Oct; 27(5):343-51. PubMed ID: 11679086
[TBL] [Abstract][Full Text] [Related]
32. Phosphorylated mitogen-activated protein kinase (MAPK/ERK-P), protein kinase of 38 kDa (p38-P), stress-activated protein kinase (SAPK/JNK-P), and calcium/calmodulin-dependent kinase II (CaM kinase II) are differentially expressed in tau deposits in neurons and glial cells in tauopathies.
Ferrer I; Blanco R; Carmona M; Puig B
J Neural Transm (Vienna); 2001; 108(12):1397-415. PubMed ID: 11810404
[TBL] [Abstract][Full Text] [Related]
33. Neuroimmune proteins can differentiate between tauopathies.
Cherry JD; Baucom ZH; Eppich KG; Kirsch D; Dixon ER; Tripodis Y; Bieniek KF; Farrell K; Whitney K; Uretsky M; Crary JF; Dickson D; McKee AC
J Neuroinflammation; 2022 Nov; 19(1):278. PubMed ID: 36403052
[TBL] [Abstract][Full Text] [Related]
34. Pin1 colocalization with phosphorylated tau in Alzheimer's disease and other tauopathies.
Ramakrishnan P; Dickson DW; Davies P
Neurobiol Dis; 2003 Nov; 14(2):251-64. PubMed ID: 14572447
[TBL] [Abstract][Full Text] [Related]
35. Novel tau filament fold in corticobasal degeneration.
Zhang W; Tarutani A; Newell KL; Murzin AG; Matsubara T; Falcon B; Vidal R; Garringer HJ; Shi Y; Ikeuchi T; Murayama S; Ghetti B; Hasegawa M; Goedert M; Scheres SHW
Nature; 2020 Apr; 580(7802):283-287. PubMed ID: 32050258
[TBL] [Abstract][Full Text] [Related]
36. Neuroligin-1 in brain and CSF of neurodegenerative disorders: investigation for synaptic biomarkers.
Camporesi E; Lashley T; Gobom J; Lantero-Rodriguez J; Hansson O; Zetterberg H; Blennow K; Becker B
Acta Neuropathol Commun; 2021 Feb; 9(1):19. PubMed ID: 33522967
[TBL] [Abstract][Full Text] [Related]
37. Increased pro-nerve growth factor and decreased brain-derived neurotrophic factor in non-Alzheimer's disease tauopathies.
Belrose JC; Masoudi R; Michalski B; Fahnestock M
Neurobiol Aging; 2014 Apr; 35(4):926-33. PubMed ID: 24112788
[TBL] [Abstract][Full Text] [Related]
38. Tau Isoform Profile in Essential Tremor Diverges From Other Tauopathies.
Kim SH; Farrell K; Cosentino S; Vonsattel JG; Faust PL; Cortes EP; Bennet DA; Louis ED; Crary JF
J Neuropathol Exp Neurol; 2021 Sep; 80(9):835-843. PubMed ID: 34363663
[TBL] [Abstract][Full Text] [Related]
39. Direct analysis of tau from PSP brain identifies new phosphorylation sites and a major fragment of N-terminally cleaved tau containing four microtubule-binding repeats.
Wray S; Saxton M; Anderton BH; Hanger DP
J Neurochem; 2008 Jun; 105(6):2343-52. PubMed ID: 18315566
[TBL] [Abstract][Full Text] [Related]
40. Thioflavin S Staining and Amyloid Formation Are Unique to Mixed Tauopathies.
Fiock KL; Betters RK; Hefti MM
J Histochem Cytochem; 2023 Feb; 71(2):73-86. PubMed ID: 36861683
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
